BEAT Quote, Financials, Valuation and Earnings

Mitesco, Inc. has a net margin of -- compared to HeartBeam, Inc.'s net margin of -106766.67%. HeartBeam, Inc.'s return on equity of -555.14% beat Mitesco, Inc.'s return on equity of --.

HeartBeam, Inc. has a consensus price target of $4.63, signalling upside risk potential of 223.43%. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 345.12%. Given that Mitesco, Inc. has higher upside potential than HeartBeam, Inc., analysts believe Mitesco, Inc. is more attractive than HeartBeam, Inc..

HeartBeam, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.563, suggesting its more volatile than the S&P 500 by 456.284%.

HeartBeam, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartBeam, Inc. pays -- of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.

HeartBeam, Inc. quarterly revenues are --, which are smaller than Mitesco, Inc. quarterly revenues of $3K. HeartBeam, Inc.'s net income of -$5.3M is lower than Mitesco, Inc.'s net income of -$3.2M. Notably, HeartBeam, Inc.'s price-to-earnings ratio is -- while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam, Inc. is -- versus 22.60x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

OneMedNet Corp. has a net margin of -- compared to HeartBeam, Inc.'s net margin of -418.64%. HeartBeam, Inc.'s return on equity of -555.14% beat OneMedNet Corp.'s return on equity of --.

HeartBeam, Inc. has a consensus price target of $4.63, signalling upside risk potential of 223.43%. On the other hand OneMedNet Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that HeartBeam, Inc. has higher upside potential than OneMedNet Corp., analysts believe HeartBeam, Inc. is more attractive than OneMedNet Corp..

HeartBeam, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison OneMedNet Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

HeartBeam, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OneMedNet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartBeam, Inc. pays -- of its earnings as a dividend. OneMedNet Corp. pays out -- of its earnings as a dividend.

HeartBeam, Inc. quarterly revenues are --, which are smaller than OneMedNet Corp. quarterly revenues of $177K. HeartBeam, Inc.'s net income of -$5.3M is lower than OneMedNet Corp.'s net income of -$741K. Notably, HeartBeam, Inc.'s price-to-earnings ratio is -- while OneMedNet Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam, Inc. is -- versus 56.46x for OneMedNet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -- compared to HeartBeam, Inc.'s net margin of 9.46%. HeartBeam, Inc.'s return on equity of -555.14% beat Spok Holdings, Inc.'s return on equity of 10.88%.

HeartBeam, Inc. has a consensus price target of $4.63, signalling upside risk potential of 223.43%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 58.73%. Given that HeartBeam, Inc. has higher upside potential than Spok Holdings, Inc., analysts believe HeartBeam, Inc. is more attractive than Spok Holdings, Inc..

HeartBeam, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.

HeartBeam, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.45% to investors and pays a quarterly dividend of $0.31 per share. HeartBeam, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

HeartBeam, Inc. quarterly revenues are --, which are smaller than Spok Holdings, Inc. quarterly revenues of $33.9M. HeartBeam, Inc.'s net income of -$5.3M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, HeartBeam, Inc.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam, Inc. is -- versus 1.96x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Vaso Corp. has a net margin of -- compared to HeartBeam, Inc.'s net margin of 7.55%. HeartBeam, Inc.'s return on equity of -555.14% beat Vaso Corp.'s return on equity of 9.61%.

HeartBeam, Inc. has a consensus price target of $4.63, signalling upside risk potential of 223.43%. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that HeartBeam, Inc. has higher upside potential than Vaso Corp., analysts believe HeartBeam, Inc. is more attractive than Vaso Corp..

HeartBeam, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.466, suggesting its less volatile than the S&P 500 by 53.413%.

HeartBeam, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartBeam, Inc. pays -- of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.

HeartBeam, Inc. quarterly revenues are --, which are smaller than Vaso Corp. quarterly revenues of $22.7M. HeartBeam, Inc.'s net income of -$5.3M is lower than Vaso Corp.'s net income of $1.7M. Notably, HeartBeam, Inc.'s price-to-earnings ratio is -- while Vaso Corp.'s PE ratio is 12.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam, Inc. is -- versus 0.37x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.